Showing 2031-2040 of 3329 results for "".
- Systematic Review Examines Hematoma Reduction Techniques in Faceliftshttps://modernaesthetics.com/news/systematic-review-examines-hematoma-reduction-techniques-in-facelifts/2484473/A new systematic review and meta-analysis published in Facial Plastic Surgery & Aesthetic Medicine underscores the incidence of hematoma after rhytidectomy and evaluates commonly used adjunctive techniques aimed at reducing this complication. The analysis focused on patients undergoi
- AAFPRS Forecasts Regeneration, Precision, and Personalization as Defining Aesthetic Trends for 2026https://modernaesthetics.com/news/aafprs-forecasts-regeneration-precision-and-personalization-as-defining-aesthetic-trends-for-2026/2484425/Aesthetic medicine is rapidly evolving beyond enhancement and rejuvenation, moving toward regenerative, precision-driven care tailored to the individual. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released its annual aesthetic trend forecast, highlighting the t
- PlasmaGLO HALO Mask Expands LED Therapy to Face, Neck, and Scalphttps://modernaesthetics.com/news/plasmaglo-halo-mask-expands-led-therapy-to-face-neck-and-scalp/2484403/Rajani MD has announced the release of the PlasmaGLO HALO Mask, a second-generation at-home LED light therapy device intended to treat signs of aging across the face, neck, and scalp. The new device builds on the brand’s original PlasmaGLO LED Mask by expanding treatment zones to include the hair
- CollPlant Launches US Logistics Hub to Support North American Growthhttps://modernaesthetics.com/news/collplant-launches-us-logistics-hub-to-support-north-american-growth/2484120/CollPlant Biotechnologies has expanded its North American operations through a new partnership with a US-based logistics hub, the company announced. The center, expected to become operational this quarter, will support the growing distribution needs for CollPlant’s recombinant human collagen (rhC
- Dr. Woolery-Lloyd Appointed Program Development Advisor for Skin of Color Updatehttps://modernaesthetics.com/news/dr-woolery-lloyd-appointed-program-development-advisor-for-skin-of-color-update/2484015/Heather Woolery-Lloyd, MD, FAAD, has been appointed program development advisor for Skin of Color Update, the nation’s largest medical education event focused on dermatologic care for patients with skin of color. Dr. Woolery-Lloyd serves as director of the Skin of Color Division at the Uni
- BTL Files Patent Infringement Lawsuit Against WonderFace Devicehttps://modernaesthetics.com/news/btl-files-patent-infringement-lawsuit-against-wonderface-device/2483957/BTL Group has filed a patent infringement claim before the Unified Patent Court against Lexter Microelectronic Engineering Systems S.L., the company behind the WonderFace device. The claim centers on BTL’s proprietary technology used in its EMFACE system, which integrates selective muscle
- Research Shows Recombinant Pure PDGF Improves Aesthetic Results, Patient Satisfaction Following RF Microneedlinghttps://modernaesthetics.com/news/research-recombinant-pure-pdgf-improves-aesthetic-results-patient-satisfaction-radio-frequency-microneedling/2483898/Research published in the Journal of Cosmetic Dermatology evaluates the efficacy and safety of topical application of pure platelet-derived growth factor (PDGF) compared with standard of care following radiofrequency (RF) microneedling. A prospective, evaluator-blinded, randomize
- Registration Open for 2026 Octane Aesthetics Tech Forumhttps://modernaesthetics.com/news/registration-open-for-2026-octane-aesthetics-tech-forum/2483870/Aesthetic executives, leading physicians, and entrepreneurs will dive into the latest trends and technology in aesthetic medicine at the 2026 Octane Aesthetics Tech Forum. The 2-day forum will be held January 8-9 at the Pendry in Newport Beach, California. The agenda includes sessions on
- GLP-1 Demand Holds Steady in Aesthetic Clinics Despite Regulatory Shiftshttps://modernaesthetics.com/news/glp-1-demand-holds-steady-in-aesthetic-clinics-despite-regulatory-shifts/2483599/Despite regulatory uncertainty and reported shortages, aesthetic practices continue to experience high demand for glucagon-like peptide-1 (GLP-1) receptor agonists, according to a report released by Guidepoint Qsight on October 1, 2025.
- Study Evaluates Ready-To-Use Botox for Lateral Canthal, Glabellar Lines Treatmenthttps://modernaesthetics.com/news/study-evaluates-ready-to-use-botox-for-lateral-canthal-glabellar-lines-treatment/2483549/Newly published research in Dermatologic Surgery found liquid nivobotulinumtoxinA was effective and well-tolerated in treating moderate-to-severe lateral canthal lines (LCLs) and glabellar lines (GLs). Jean Carruthers, MD, FRCSC, FRC, co-authored the study, titled “NivobotulinumtoxinA in